MCRB (Seres Therapeutics Inc) may reap gains as insiders became active recently
Seres Therapeutics Inc’s recently made public that its CEO and President Shaff Eric D. unloaded Company’s shares for reported $12473.0 on Feb 16 ’24. In the deal valued at $1.08 per share,11,549 shares were sold. As a result of this transaction, Shaff Eric D. now holds 135,321 shares worth roughly $86605.44. Then, Ege David S. […]
Oppenheimer gives an Outperform recommendation for Seres Therapeutics Inc (MCRB)
In a filing, Seres Therapeutics Inc revealed its CEO and President Shaff Eric D. unloaded Company’s shares for reported $12473.0 on Feb 16 ’24. In the deal valued at $1.08 per share,11,549 shares were sold. As a result of this transaction, Shaff Eric D. now holds 135,321 shares worth roughly $96077.90999999999. Then, Ege David S. […]
Oppenheimer gives an Outperform recommendation for Seres Therapeutics Inc (MCRB)
Seres Therapeutics Inc’s recently made public that its CEO and President Shaff Eric D. unloaded Company’s shares for reported $12473.0 on Feb 16 ’24. In the deal valued at $1.08 per share,11,549 shares were sold. As a result of this transaction, Shaff Eric D. now holds 135,321 shares worth roughly $0.1 million. Then, Ege David […]
Oppenheimer gives an Outperform recommendation for Seres Therapeutics Inc (MCRB)
Seres Therapeutics Inc’s filing revealed that its CEO and President Shaff Eric D. unloaded Company’s shares for reported $12473.0 on Feb 16 ’24. In the deal valued at $1.08 per share,11,549 shares were sold. As a result of this transaction, Shaff Eric D. now holds 135,321 shares worth roughly $0.1 million. Then, Ege David S. […]
